Lv2
178 积分 2024-08-03 加入
HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy
23小时前
已完结
Mitochondria-targeted drug delivery system based on tetrahedral framework nucleic acids for bone regeneration under oxidative stress
2天前
已完结
Harnessing tissue-derived mitochondria-rich extracellular vesicles (Ti-mitoEVs) to boost mitochondrial biogenesis for regenerative medicine
2天前
已完结
Glycoengineered stem cell-derived extracellular vesicles for targeted therapy of acute kidney injury
2天前
已完结
Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment
3天前
已完结
Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy
3天前
已完结
HA/CD44–SS31 Mitochondrial Targeting of Manganese Oxide Nanozymes for Ischemia-Reperfusion-Induced Acute Kidney Injury Therapy
3天前
已完结
Therapeutic Approaches Involving Mitochondria in the Treatment of Acute Kidney Injury
1个月前
已完结
Ultrasmall Polyphenol‐NAD+ Nanoparticle‐Mediated Renal Delivery for Mitochondrial Repair and Anti‐Inflammatory Treatment of AKI‐to‐CKD Progression
2个月前
已完结
Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy
2个月前
已完结
皖公网安备34019202002308
